Analysis of HER Family (HER1-4) Expression as a Biomarker in Combination Therapy with Pertuzumab, Trastuzumab and Docetaxel for Advanced HER2-positive Breast Cancer
| Image |  |
|---|---|
| Description | scientific article published in April 2018 |
| Author/s |
author: Tsutomu Takashima |
| Publication date | April 1, 2018 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |